Position in ACRS
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,917,978
+$1,102,723 QoQ
Shares Held
511,461
+88.8% QoQ
Ownership
0.366%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 75.26438966020869.ToString("F0")%
Shared 16.82181046062163.ToString("F0")%
None 7.913799879169672.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. ACRS ranks #125 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in ACRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,917,978 | 511,461 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $815,255 | 270,850 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $312,062 | 164,244 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $294,326 | 207,273 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $542,916 | 354,849 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $594,194 | 239,595 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $88,330 | 76,810 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $84,434 | 76,759 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $110,435 | 89,061 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $196,930 | 187,553 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,792,870 | 261,733 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,041,738 | 100,457 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,115,796 | 137,923 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $756,267 | 48,017 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $755,787 | 48,017 | Shares | Sole | 2022-11-10 | |
| 2021-09-30 | $335,520 | 18,640 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $327,318 | 18,640 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $469,728 | 18,640 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $120,600 | 18,640 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $47,884 | 18,632 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $18,489 | 11,413 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $11,869 | 11,413 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||